Expanded Access Allows Compassionate Use of Investigational Drugs When Few Options Exist
By
[email protected] (Linda Maxwell)
1mo agoen
Source
ltcnews.comExpanded Access Allows Compassionate Use of Investigational Drugs When Few Options Existltcnews.comExpanded access programs — sometimes called "compassionate use" — allow patients with serious or life-threatening conditions to try investigational medications when no approved alternatives exist. These FDA-overseen programs can be a critical option for patients with hepatocellular carcinoma and other advanced diseases.
You might also wanna read
New drug for cancer patients with ‘limited’ treatment options enters clinical trial
The Independent·2d ago
CMS launches ACCESS 10-year pilot to expand tech-enabled chronic care in Original Medicare
CMS announced the ACCESS model, a nationwide, voluntary 10-year pilot program starting July 5, 2026, that tests outcome-aligned payments and
citizenportal.ai·24d ago
China creates new regulatory pathway to accelerate access to advanced biomedical therapies
China has established a new regulatory "tech track" for advanced therapies like personalized cancer treatments, cell and gene therapies, and
biopharmadive.com·23d ago
New cancer drug trial offers hope for patients with rare aggressive tumour
Reading Chronicle·21h ago
FDA-approved drug may finally help immunotherapy defeat rare liver cancer
ScienceDaily·13d ago
AGA Updates Clinical Guidance for Obesity and Weight Management Treatment Options
The American Gastroenterological Association (AGA) has updated its POWER (Practice Guide on Obesity and Weight Management, Education, and Re
mdsc.pe·18d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.